Resources for Medical Practices
Regulatory updates, implementation guides, and comparison tools to help your practice launch and grow cash-pay specialty programs.
Peptide Therapy Legal Guide for Practices [2026]
A detailed legal reference for medical practices offering peptide therapy in 2026. Covers FDA bulk drug substance categories, the HHS reclassification announcement, state prescribing authority, DEA considerations, informed consent requirements, and documentation best practices.
Telehealth Prescribing for Peptides and GLP-1: What Providers Need to Know
A complete guide to the regulatory environment for telehealth prescribing of compounded peptides and GLP-1 medications. Covers federal requirements, state-by-state considerations, the Ryan Haight Act, DEA rules, and practical compliance strategies for telehealth practices.
Direct-to-Patient Pharmacy Fulfillment: How It Works for Practices
A complete guide to the direct-to-patient pharmacy fulfillment model for medical practices. Covers the prescription-to-delivery workflow, cold chain shipping for peptides, state shipping regulations, patient communication, and how platform integration eliminates operational overhead.
Patient Intake Workflows for Peptide and GLP-1 Clinics
A detailed look at the ideal patient intake workflow for clinics offering peptide therapy and GLP-1 programs. From first contact to first prescription, with strategies for automation, AI triage, and operational efficiency.
Adding Medical Weight Loss to Your Med Spa: A Step-by-Step Guide
A practical guide for med spas adding GLP-1 medical weight loss programs. Covers the aesthetic-weight loss crossover opportunity, staffing and prescriber requirements, marketing to existing patients, pricing strategy, and white-label platform options.
HIPAA Compliance for Cash-Pay Medication Programs
A practical guide to HIPAA compliance for cash-pay medical practices offering peptide therapy, GLP-1 weight loss, TRT, and HRT programs. Covers PHI handling, BAA requirements, telehealth considerations, breach notification, and minimum necessary standards.
Starting a TRT Program at Your Practice: The Complete Guide
Everything a medical practice needs to launch a TRT program: patient screening criteria, lab protocols, prescribing workflows, monitoring schedules, pharmacy selection, compliance considerations, and the business case for testosterone replacement therapy.
Compounded Semaglutide vs Brand Name: What Providers Need to Know
A clinical and regulatory comparison of compounded semaglutide versus brand-name Ozempic and Wegovy. Covers FDA shortage status, legal compounding pathways, quality considerations, pricing differences, and what happens when the shortage ends.
The Cash-Pay GLP-1 and Peptide Revenue Model: What Practices Actually Earn
A transparent look at the economics of cash-pay medication programs for medical practices. Covers revenue per patient, overhead costs, staff time, pharmacy margins, and how cash-pay compares to insurance-based models.
503A vs 503B Pharmacies: Which Type Does Your Practice Need?
A detailed comparison of 503A and 503B compounding pharmacies for medical practice owners. Covers the DQSA legal framework, FDA oversight differences, cGMP requirements, multi-state considerations, and how to select the right pharmacy type for your clinical programs.
Automated Patient Follow-Up for GLP-1 and Peptide Practices
A practical guide for medical practices on automating patient follow-up in cash-pay specialty programs. Covers check-in schedules, refill reminders, reactivation campaigns, and how AI agents handle routine patient communication.
How to Choose a Compounding Pharmacy Partner for Your Practice
A practical evaluation framework for medical practices choosing compounding pharmacy partners. Covers regulatory pathways, quality benchmarks, fulfillment models, and what to look for in a pharmacy relationship.
GLP-1 Compounding Regulations 2026: What Changed for Medical Practices
A detailed breakdown of GLP-1 compounding regulations as of 2026. Covers the FDA semaglutide shortage resolution, enforcement timelines, 503A and 503B pathways, and strategies for practices running medical weight loss programs.
How to Start a Peptide Therapy Program at Your Practice [2026 Guide]
A complete guide for medical practices ready to add peptide therapy as a cash-pay program. From choosing the right peptides and pharmacy partners to setting up clinical workflows and marketing to patients.
FDA Peptide Reclassification 2026: What Medical Practices Need to Know
In February 2026, HHS Secretary RFK Jr. announced plans to reclassify approximately 14 peptides back to Category 1. Here is what medical practices need to know about the expected changes, which peptides are affected, and how to prepare your practice for peptide therapy.